{"disease":{"id":"gastro-esophageal-reflux","name":"gastro esophageal reflux"},"drugs":{"marketed":[{"drug_id":"omeprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prilosec","generic_name":"omeprazole","company_name":"AstraZeneca (originally Astra AB)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19","drug_class":"Proton pump inhibitor (PPI)","quality_score":50,"revenue":"1041.0","mechanism":"Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) in gastric parietal cells, potently suppressing stomach acid secretion."},{"drug_id":"dexlansoprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexilant","generic_name":"DEXLANSOPRAZOLE","company_name":"Takeda","drug_phase":"marketed","molecular_target":"(H+, K+)-ATPase","drug_class":"Proton Pump Inhibitor [EPC]","quality_score":67,"revenue":"300","mechanism":"Dexlansoprazole inhibits gastric acid secretion by blocking the (H+, K+)-ATPase enzyme, known as the proton pump, in gastric parietal cells."},{"drug_id":"dexrabeprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexpure","generic_name":"dexrabeprazole","company_name":"","drug_phase":"unknown","molecular_target":"Proto-oncogene tyrosine-protein kinase receptor Ret","drug_class":"Proton Pump Inhibitors","quality_score":null,"revenue":null,"mechanism":"Dexpure works by irreversibly inhibiting the H+/K+ ATPase enzyme in the stomach lining, reducing acid production."},{"drug_id":"metaclopramide","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metaclopramide","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"sodium-citrate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bss","generic_name":"SODIUM CITRATE","company_name":"B Braun","drug_phase":"marketed","molecular_target":"Calcium","drug_class":"sodium citrate","quality_score":51,"revenue":null,"mechanism":"ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A prevents blood clotting by binding free calcium, a crucial co-factor in the clotting cascade."},{"drug_id":"magnesium-silicate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gaviscon","generic_name":"MAGNESIUM SILICATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"","drug_class":"magnesium silicate","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"magnesium-carbonate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Renacidin","generic_name":"MAGNESIUM CARBONATE","company_name":"United Guardian","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"magnesium-hydroxide","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Milk of Magnesia","generic_name":"magnesium hydroxide","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Gastric acid (direct neutralization) + osmotic effect in intestine","drug_class":"Osmotic laxative, Antacid","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"METOCLOPRAMIDE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide-hydrochloride","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"Metoclopramide Hydrochloride","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Acetylcholine receptor sensitization; dopamine antagonism (implied)","drug_class":"Prokinetic agent","quality_score":10,"revenue":null,"mechanism":"Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action."},{"drug_id":"lafutidine","indication_name":"Gastro-esophageal reflux disease with esophagitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Protecadin","generic_name":"LAFUTIDINE","company_name":"","drug_phase":"phase_3","molecular_target":"","drug_class":"lafutidine","quality_score":10,"revenue":null,"mechanism":"Protecadin works by blocking histamine H2 receptors to reduce stomach acid production."},{"drug_id":"ilaprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noltec","generic_name":"ILAPRAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton Pump Inhibitors","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"ranitidine","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zantac","generic_name":"ranitidine","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Acetylcholinesterase, Histamine H2 receptor","drug_class":"H2 receptor antagonist","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"dexlan","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dexlan","company_name":"Chang Gung Memorial Hospital","drug_phase":"phase_1","molecular_target":"Sterile alpha and TIR motif-containing protein 1, Cytosolic endo-beta-N-acetylglucosaminidase, Potassium-transporting ATPase","drug_class":"","quality_score":7,"revenue":null,"mechanism":""},{"drug_id":"famotidine","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pepcid","generic_name":"famotidine","company_name":"Generic (originally Yamanouchi/Merck)","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2, Solute carrier family 22 member 2","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":56,"revenue":null,"mechanism":"Competitively blocks histamine H2 receptors on gastric parietal cells, reducing basal and stimulated acid secretion."},{"drug_id":"dexilant","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dexilant","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Sterile alpha and TIR motif-containing protein 1, Cytosolic endo-beta-N-acetylglucosaminidase, Potassium-transporting ATPase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"algeldrate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gaviscon","generic_name":"ALGELDRATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"","drug_class":"algeldrate","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"palazestrant","indication_name":"Treatment of gastroesophageal reflux disease (GERD) in patients who have not responded adequately to proton pump inhibitor (PPI) therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Palazestrant","generic_name":"palazestrant","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"estrogen receptor","drug_class":"estrogen receptor antagonist and degrader","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"prevacid","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prevacid","company_name":"Vanderbilt University Medical Center","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 2C19, Cytosolic endo-beta-N-acetylglucosaminidase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"esomeprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nexium","generic_name":"esomeprazole","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton pump inhibitor (PPI)","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"pantoprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Protonix","generic_name":"pantoprazole","company_name":"Generic (originally Byk Gulden/Altana/Nycomed)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Fatty acid synthase, Multidrug and toxin extrusion protein 1","drug_class":"Proton pump inhibitor (PPI)","quality_score":58,"revenue":null,"mechanism":"Irreversibly inhibits the gastric proton pump (H+/K+ ATPase), suppressing stomach acid secretion."},{"drug_id":"revaprazan","indication_name":"Gastro-esophageal reflux disease with esophagitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revanex","generic_name":"REVAPRAZAN","company_name":"","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"revaprazan","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"camostat","indication_name":"Gastro-esophageal reflux disease with esophagitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CAMOSTAT","company_name":"","drug_phase":"discontinued","molecular_target":"Serine protease hepsin","drug_class":"camostat","quality_score":null,"revenue":null,"mechanism":"CAMOSTAT works by blocking the activity of hepsin, a protease that contributes to inflammation and tissue damage."},{"drug_id":"aluminum-carbonate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"aluminum carbonate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"aluminum carbonate","quality_score":null,"revenue":null,"mechanism":"Aluminum carbonate works by neutralizing stomach acid and forming a protective barrier over the stomach lining."},{"drug_id":"carbaldrate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"carbaldrate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"carbaldrate","quality_score":null,"revenue":null,"mechanism":"Carbaldrate works by reducing stomach acid production."},{"drug_id":"almasilate","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gelusil","generic_name":"ALMASILATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"almasilate","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"alum","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Potassium Alum","generic_name":"Alum","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"protonix-iv","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pantoprazole Sodium","generic_name":"Pantoprazole Sodium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"(H+, K+)-ATPase enzyme","drug_class":"Proton pump inhibitor (PPI)","quality_score":69,"revenue":null,"mechanism":"Pantoprazole suppresses gastric acid by covalently binding the (H+, K+)-ATPase enzyme at parietal cells."},{"drug_id":"aciphex","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aciphex","company_name":"University of Utah","drug_phase":"marketed","molecular_target":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"aciphex","indication_name":"Maintenance of Healing Gastroesophageal Reflux","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aciphex","company_name":"University of Utah","drug_phase":"marketed","molecular_target":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"rabeprazole-40-mg","indication_name":"Gastroesophageal Reflux Disease (GERD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rabeprazole 40 mg","generic_name":"rabeprazole-40-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"H+/K+ ATPase","drug_class":"Proton Pump Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"rabeprazole-40-mg","indication_name":"Gastroesophageal Reflux Disease (GERD) in Pediatric Patients 1 to 11 Years Old","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rabeprazole 40 mg","generic_name":"rabeprazole-40-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"H+/K+ ATPase","drug_class":"Proton Pump Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"cimetidine","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tagamet","generic_name":"CIMETIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H2 receptor","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"rabeprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aciphex","generic_name":"rabeprazole","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton Pump Inhibitor","quality_score":80,"revenue":null,"mechanism":"Aciphex works by irreversibly inhibiting the potassium-transporting ATPase enzyme in the stomach lining, reducing acid production."},{"drug_id":"rabeprazole","indication_name":"Maintenance of Healing Gastroesophageal Reflux","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aciphex","generic_name":"rabeprazole","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton Pump Inhibitor","quality_score":80,"revenue":null,"mechanism":"Aciphex works by irreversibly inhibiting the potassium-transporting ATPase enzyme in the stomach lining, reducing acid production."},{"drug_id":"cisapride","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alimix","generic_name":"CISAPRIDE","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"High Risk QT Prolonging Agents","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"nizatidine","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Axid Ar","generic_name":"NIZATIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H2 receptor","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"takecab","indication_name":"Gastro-esophageal reflux disease with esophagitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Takecab","company_name":"Genuine Research Center, Egypt","drug_phase":"phase_1","molecular_target":"Potassium-transporting ATPase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"rabeprazol","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rabeprazol","company_name":"Janssen-Cilag, S.A.","drug_phase":"discontinued","molecular_target":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"rabeprazol","indication_name":"Maintenance of Healing Gastroesophageal Reflux","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rabeprazol","company_name":"Janssen-Cilag, S.A.","drug_phase":"discontinued","molecular_target":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"omeprazol","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Omeprazol","company_name":"RenJi Hospital","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pantoprazol","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pantoprazol","company_name":"Northern Orthopaedic Division, Denmark","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Fatty acid synthase, Multidrug and toxin extrusion protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sulfur-colloid","indication_name":"Esophageal transit and gastroesophageal reflux studies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sulfur Colloid","company_name":"University of California, San Diego","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":"Technetium Tc 99m Sulfur Colloid is used for imaging by entering lymphatic capillaries, mixing with peritoneal fluid, or being taken up by the reticuloendothelial system."},{"drug_id":"lansoprazole","indication_name":"Gastroesophageal reflux disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevacid","generic_name":"lansoprazole","company_name":"Generic (originally Takeda)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 2C19, Cytosolic endo-beta-N-acetylglucosaminidase","drug_class":"Proton pump inhibitor (PPI)","quality_score":null,"revenue":null,"mechanism":"Irreversibly inhibits the gastric proton pump to suppress acid secretion."},{"drug_id":"sulfur-colloid","indication_name":"Esophageal transit and gastroesophageal reflux studies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sulfur Colloid","company_name":"University of California, San Diego","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":"Technetium Tc 99m Sulfur Colloid is used for imaging by entering lymphatic capillaries, mixing with peritoneal fluid, or being taken up by the reticuloendothelial system."}],"pipeline":[],"offLabel":[],"totalMarketed":45,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04312633","title":"Clinical Utility of WATS3D: A 5-Year Prospective Study","phase":"","overall_status":"RECRUITING","enrollment_count":90000,"lead_sponsor_name":"CDx Diagnostics","has_results":false},{"nct_id":"NCT03824548","title":"Outcomes for Patients With Gastro-Esophageal Reflux Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Tianjin Happy Life Technology Co., Ltd.","has_results":false},{"nct_id":"NCT03524781","title":"Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":36292,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT06974903","title":"Retrospective Observational Study on GERD Management in General Hospitals in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":13750,"lead_sponsor_name":"Chong Kun Dang Pharmaceutical","has_results":false},{"nct_id":"NCT05614752","title":"Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab","phase":"","overall_status":"COMPLETED","enrollment_count":10067,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT04494048","title":"Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry","phase":"","overall_status":"RECRUITING","enrollment_count":9999,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05886933","title":"Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet","phase":"","overall_status":"COMPLETED","enrollment_count":9846,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT07115706","title":"JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7150,"lead_sponsor_name":"Jeil Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05689918","title":"Gastroesophageal Reflux Disease in the Dutch Population","phase":"","overall_status":"UNKNOWN","enrollment_count":4719,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04034017","title":"Gastroesophageal Reflux Disease Among College Students","phase":"","overall_status":"COMPLETED","enrollment_count":2878,"lead_sponsor_name":"King Khalid University","has_results":false},{"nct_id":"NCT05660122","title":"A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab","phase":"","overall_status":"COMPLETED","enrollment_count":2852,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT05870163","title":"Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Implantica CE Reflux Ltd.","has_results":false},{"nct_id":"NCT04846010","title":"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"All Natural Medicine Clinic, LLC","has_results":false},{"nct_id":"NCT06585176","title":"Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City","phase":"","overall_status":"COMPLETED","enrollment_count":1625,"lead_sponsor_name":"Zhongshan Hospital (Xiamen), Fudan University","has_results":false},{"nct_id":"NCT03868267","title":"Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Hamilton Health Sciences Corporation","has_results":false},{"nct_id":"NCT06504134","title":"Gastroesophageal Reflux Disease Diagnostic Trial","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07482969","title":"Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Motol","has_results":false},{"nct_id":"NCT03616119","title":"Gastroesophageal Reflux Disease in Azerbaijan","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sevda Aghayeva","has_results":false},{"nct_id":"NCT06687603","title":"Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05195528","title":"A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":776,"lead_sponsor_name":"Phathom Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04408105","title":"Survey Study on Barrett's Esophagus Screening","phase":"","overall_status":"COMPLETED","enrollment_count":725,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06381583","title":"A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":658,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT02530216","title":"Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT03561883","title":"Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":609,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT00431756","title":"Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06693622","title":"Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests","phase":"","overall_status":"RECRUITING","enrollment_count":556,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04253392","title":"RETHINK REFLUX Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Ethicon Endo-Surgery","has_results":false},{"nct_id":"NCT07004439","title":"A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Implantica CE Reflux Ltd.","has_results":false},{"nct_id":"NCT04306380","title":"Transoral Incisionless Fundoplication Database Repository (TIF)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT03561090","title":"A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":495,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02907632","title":"Methoclopramide for Gastroesophageal Reflux in Premature Infants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Nathalie Charpak","has_results":false},{"nct_id":"NCT02954848","title":"Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":484,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT01472939","title":"Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06151067","title":"Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease","phase":"","overall_status":"COMPLETED","enrollment_count":458,"lead_sponsor_name":"Evangelic Hospital Kalk Cologne","has_results":false},{"nct_id":"NCT04799158","title":"A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":458,"lead_sponsor_name":"Phathom Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03077906","title":"Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Pierre Wauthy","has_results":false},{"nct_id":"NCT04771221","title":"Method of Early Diagnosis of Laryngopharyngeal Reflux","phase":"NA","overall_status":"COMPLETED","enrollment_count":385,"lead_sponsor_name":"Kazakh Medical University of Continuing Education","has_results":false},{"nct_id":"NCT07127276","title":"Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":380,"lead_sponsor_name":"Institute of Gastroenterology and Hepatology, Vietnam","has_results":false},{"nct_id":"NCT07125521","title":"Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare","phase":"NA","overall_status":"RECRUITING","enrollment_count":380,"lead_sponsor_name":"Institute of Gastroenterology and Hepatology, Vietnam","has_results":false},{"nct_id":"NCT05068089","title":"Health, Economic Analysis and Clinical Aspects of Patients With Neurological Disabilities in Enteral Nutrition With Dedicated Formula. The Role of Nissen's Fundoplication in the Management of Gastroesophageal Reflux","phase":"","overall_status":"UNKNOWN","enrollment_count":360,"lead_sponsor_name":"Bambino Gesù Hospital and Research Institute","has_results":false},{"nct_id":"NCT05697393","title":"External UES Band (Shaker Pressure Band) and GERD","phase":"NA","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT04358146","title":"Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":346,"lead_sponsor_name":"United Pharmaceuticals","has_results":false},{"nct_id":"NCT03390634","title":"Physiological Predictors of Clinical Outcomes After Anti-reflux Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT05701540","title":"A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":338,"lead_sponsor_name":"HK inno.N Corporation","has_results":false},{"nct_id":"NCT04695171","title":"LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm","phase":"","overall_status":"TERMINATED","enrollment_count":336,"lead_sponsor_name":"Foregut Research Foundation","has_results":false},{"nct_id":"NCT04813029","title":"Thresholds of Straight Leg Raise Maneuver During High-Resolution-Manometry","phase":"NA","overall_status":"UNKNOWN","enrollment_count":336,"lead_sponsor_name":"University of Milan","has_results":false},{"nct_id":"NCT03596476","title":"Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07160790","title":"Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":321,"lead_sponsor_name":"Onconic Therapeutics Inc.","has_results":false},{"nct_id":"NCT03848494","title":"True Short Esophagus in Gastroesophageal Reflux Disease","phase":"","overall_status":"COMPLETED","enrollment_count":311,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT04720781","title":"The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Showa Inan General Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}